These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


430 related items for PubMed ID: 17715247

  • 1. Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board.
    Wittes J, Barrett-Connor E, Braunwald E, Chesney M, Cohen HJ, Demets D, Dunn L, Dwyer J, Heaney RP, Vogel V, Walters L, Yusuf S.
    Clin Trials; 2007; 4(3):218-34. PubMed ID: 17715247
    [Abstract] [Full Text] [Related]

  • 2. Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials.
    Anderson GL, Kooperberg C, Geller N, Rossouw JE, Pettinger M, Prentice RL.
    Clin Trials; 2007; 4(3):207-17. PubMed ID: 17715246
    [Abstract] [Full Text] [Related]

  • 3. Rashomon revisited: two views of monitoring the Women's Health Initiative trials.
    Goodman SN.
    Clin Trials; 2007; 4(3):205-6. PubMed ID: 17715245
    [No Abstract] [Full Text] [Related]

  • 4. The women's health initiative--curse or blessing?
    Michels KB.
    Int J Epidemiol; 2006 Aug; 35(4):814-6. PubMed ID: 16847020
    [No Abstract] [Full Text] [Related]

  • 5. [Conjugated estrogen-gestagen does not reduce cardiovascular morbidity. Were these findings (in the Women's Health Initiative study) really unexpected?].
    Henriksson P.
    Lakartidningen; 2002 Nov 21; 99(47):4716-9. PubMed ID: 12523045
    [No Abstract] [Full Text] [Related]

  • 6. Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative.
    Kaunitz AM, Women's Health Initiative.
    Medscape Womens Health; 2002 Nov 21; 7(4):8. PubMed ID: 12466740
    [No Abstract] [Full Text] [Related]

  • 7. Calcium supplementation and fracture risk--recent findings from the women's health initiative study.
    Kruse H.
    S D Med; 2006 May 21; 59(5):207-8. PubMed ID: 16729654
    [No Abstract] [Full Text] [Related]

  • 8. The last nail.
    Malik P.
    Can J Cardiol; 2004 Mar 15; 20(4):387. PubMed ID: 15085863
    [No Abstract] [Full Text] [Related]

  • 9. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.
    Naftolin F, Taylor HS, Karas R, Brinton E, Newman I, Clarkson TB, Mendelsohn M, Lobo RA, Judelson DR, Nachtigall LE, Heward CB, Hecht H, Jaff MR, Harman SM, Women's Health Initiative.
    Fertil Steril; 2004 Jun 15; 81(6):1498-501. PubMed ID: 15193467
    [Abstract] [Full Text] [Related]

  • 10. From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health.
    Gambacciani M, Genazzani AR.
    Gynecol Endocrinol; 2006 Mar 15; 22(3):115-6. PubMed ID: 16835071
    [No Abstract] [Full Text] [Related]

  • 11. Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response.
    Hartsfield CL, Connelly MT, Newton KM, Andrade SE, Wei F, Buist DS.
    J Natl Cancer Inst Monogr; 2005 Mar 15; (35):113-5. PubMed ID: 16287896
    [Abstract] [Full Text] [Related]

  • 12. What can we learn from design faults in the Women's Health Initiative randomized clinical trial?
    Tan O, Harman SM, Naftolin F.
    Bull NYU Hosp Jt Dis; 2009 Mar 15; 67(2):226-9. PubMed ID: 19583558
    [Abstract] [Full Text] [Related]

  • 13. Sex hormones and the cardiovascular system: effects on arterial function in women.
    Teede HJ.
    Clin Exp Pharmacol Physiol; 2007 Jul 15; 34(7):672-6. PubMed ID: 17581228
    [Abstract] [Full Text] [Related]

  • 14. Role of the data safety and monitoring board in an international trial.
    NIMH Collaborative HIV/STD Prevention Trial.
    AIDS; 2007 Apr 15; 21 Suppl 2():S99-102. PubMed ID: 17413269
    [Abstract] [Full Text] [Related]

  • 15. [Estrogen and cardiovascular diseases].
    Mikkola T, Tikkanen MJ.
    Duodecim; 2003 Apr 15; 119(22):2191-7. PubMed ID: 14702808
    [No Abstract] [Full Text] [Related]

  • 16. Statistical issues arising in the Women's Health Initiative.
    Prentice RL, Pettinger M, Anderson GL.
    Biometrics; 2005 Dec 15; 61(4):899-911; discussion 911-41. PubMed ID: 16401257
    [Abstract] [Full Text] [Related]

  • 17. Women's cognitive health: postmenopausal dementia and the women's health initiative memory study.
    Klein KP, Rapp SR.
    Womens Health Issues; 2004 Dec 15; 14(3):71-4. PubMed ID: 15193634
    [No Abstract] [Full Text] [Related]

  • 18. Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income.
    Wei F, Miglioretti DL, Connelly MT, Andrade SE, Newton KM, Hartsfield CL, Chan KA, Buist DS.
    J Natl Cancer Inst Monogr; 2005 Dec 15; (35):106-12. PubMed ID: 16287895
    [Abstract] [Full Text] [Related]

  • 19. Hormone therapy and cardiovascular disease in the early postmenopause: the WHI data revisited.
    Pines A, Sturdee DW, Birkhäuser MH, International Menopause Society.
    Climacteric; 2007 Jun 15; 10(3):195-6. PubMed ID: 17487646
    [No Abstract] [Full Text] [Related]

  • 20. Do diet, folic acid, and vitamins matter? What did we learn from the Women's Health Initiative, the Women's Health Study, the Women's Antioxidant and Folic Acid Cardiovascular Study, and other clinical trials?
    Wenger NK.
    Cardiol Rev; 2007 Jun 15; 15(6):288-90. PubMed ID: 18090063
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.